Chen W, Qin H, Chesebro B, Cheever M A
Division of Oncology, Department of Medicine, University of Washington, Seattle 98195, USA.
J Virol. 1996 Nov;70(11):7773-82. doi: 10.1128/JVI.70.11.7773-7782.1996.
FBL-3 is a highly immunogenic murine leukemia of C57BL/6 origin induced by Friend murine leukemia virus (MuLV). Immunization of C57BL/6 mice with FBL-3 readily elicits CD8+ cytotoxic T lymphocytes (CTL) capable of lysing FBL-3 as well as syngeneic leukemias induced by Moloney and Rauscher MuLV. The aim of this current study was to identify the immunogenic epitope(s) recognized by the FBL-3-specific CD8+ CTL. A series of FBL-3-specific CD8+ CTL clones were generated from C57BL/6 mice immunized to FBL-3. The majority of CTL clones (32 of 38) were specific for F-MuLV gag-encoded antigen. By using a series of recombinant vaccinia viruses expressing full-length and truncated F-MuLV gag genes, the antigenic epitope recognized by the FBL-3 gag-specific CTL clones, as well as by bulk-cultured CTL from spleens of mice immune to FBL-3, was localized to the leader sequence of gPr80gag protein. The precise amino acid sequence of the CTL epitope in the leader sequence was identified as CCLCLTVFL (positions 85-93) by examining lysis of targets incubated with a series of synthetic leader sequence peptides. No evidence of other CTL epitopes in the gPr80gag or Pr65gag core virion structural polyproteins was found. The identity of CCLCLTVFL as the target peptide was validated by showing that immunization with the peptide elicited CTL that lysed FBL-3. The CTL elicited by the Gag peptide also specifically lysed syngeneic leukemia cells induced by Moloney and Rauscher MuLV (MBL-2 and RBL-5). The transmembrane peptide was shown to be the major gag-encoded antigenic epitope recognized by bulk-cultured CTL derived from C57BL/6 mice immunized to MBL-2 or RBL-5. Thus, the CTL epitope of FBL-3 is localized to the transmembrane anchor domain of the nonstructural Gag polyprotein and is shared by leukemia/lymphoma cell lines induced by Friend, Moloney, and Rauscher MuLV.
FBL-3是一种起源于C57BL/6小鼠、由Friend小鼠白血病病毒(MuLV)诱导产生的高度免疫原性的鼠白血病。用FBL-3免疫C57BL/6小鼠很容易引发能够裂解FBL-3以及由莫洛尼和劳舍尔MuLV诱导的同基因白血病的CD8+细胞毒性T淋巴细胞(CTL)。本研究的目的是鉴定FBL-3特异性CD8+CTL识别的免疫原性表位。从用FBL-3免疫的C57BL/6小鼠中产生了一系列FBL-3特异性CD8+CTL克隆。大多数CTL克隆(38个中的32个)对F-MuLV gag编码的抗原具有特异性。通过使用一系列表达全长和截短F-MuLV gag基因的重组痘苗病毒,FBL-3 gag特异性CTL克隆以及来自免疫FBL-3小鼠脾脏的大量培养CTL识别的抗原表位定位于gPr80gag蛋白的前导序列。通过检查与一系列合成前导序列肽孵育的靶细胞的裂解情况,前导序列中CTL表位的精确氨基酸序列被确定为CCLCLTVFL(第85-93位)。在gPr80gag或Pr65gag核心病毒体结构多蛋白中未发现其他CTL表位的证据。通过证明用该肽免疫引发了能够裂解FBL-3的CTL,验证了CCLCLTVFL作为靶肽的身份。由Gag肽引发的CTL也特异性裂解了由莫洛尼和劳舍尔MuLV诱导的同基因白血病细胞(MBL-2和RBL-5)。跨膜肽被证明是由免疫MBL-2或RBL-5的C57BL/6小鼠产生的大量培养CTL识别的主要gag编码抗原表位。因此,FBL-3的CTL表位定位于非结构Gag多蛋白的跨膜锚定结构域,并由Friend、莫洛尼和劳舍尔MuLV诱导的白血病/淋巴瘤细胞系共享。